title: Myeloma presenting during pregnancy.
authors.affiliation: Clinical Haematology, University College Hospital, London, UK. deansmith@doctors.org.uk.
authors.forename: Dean
authors.initials: D
authors.lastname: Smith
authors.forename: Jane
authors.initials: J
authors.lastname: Stevens
authors.forename: John
authors.initials: J
authors.lastname: Quinn
authors.forename: Jamie
authors.initials: J
authors.lastname: Cavenagh
authors.forename: Wendy
authors.initials: W
authors.lastname: Ingram
authors.forename: Kwee
authors.initials: K
authors.lastname: Yong
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D002585:Cesarean Section; D059248:Chemoradiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D000075202:Contraindications; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D015255:Idarubicin / Q000008:administration & dosage; D007231:Infant, Newborn; D000077269:Lenalidomide; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy*; D009194:Myeloma Proteins / Q000032:analysis; D010014:Osteolysis / Q000175:diagnosis / Q000209:etiology; D010954:Plasmacytoma / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D049590:Postpartum Period; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy* / Q000652:urine; D011256:Pregnancy Outcome; D011719:Pyrazines / Q000008:administration & dosage; D012074:Remission Induction; D013117:Spinal Cord Compression / Q000209:etiology; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D013904:Thoracic Vertebrae / Q000473:pathology; D014182:Transplantation, Autologous
chemical_list: D001897:Boronic Acids; D009194:Myeloma Proteins; D011719:Pyrazines; D003561:Cytarabine; D013792:Thalidomide; D000069286:Bortezomib; D005047:Etoposide; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D000077269:Lenalidomide; D002945:Cisplatin; D008558:Melphalan; D008775:Methylprednisolone; D015255:Idarubicin